000			01522 a2200397 4500
005			20250512235200.0
264		0	_c19830826
008			198308s 0 0 eng d
022			_a0735-1097
024	7		_a10.1016/s0735-1097(83)80171-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aThormann, J
245	0	0	_aEffects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cAug 1983
300			_a332-7 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAngina Pectoris _xprevention & control
650	0	4	_aCardiac Catheterization
650	0	4	_aCardiac Pacing, Artificial
650	0	4	_aCardiotonic Agents _xadverse effects
650	0	4	_aCoronary Disease _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImidazoles _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Contraction _xdrug effects
650	0	4	_aStroke Volume _xdrug effects
650	0	4	_aVascular Resistance _xdrug effects
650	0	4	_aVision, Ocular _xdrug effects
700	1		_aSchlepper, M
700	1		_aKramer, W
700	1		_aGottwik, M
700	1		_aKindler, M
773	0		_tJournal of the American College of Cardiology _gvol. 2 _gno. 2 _gp. 332-7
856	4	0	_uhttps://doi.org/10.1016/s0735-1097(83)80171-5 _zAvailable from publisher's website
999			_c6863498 _d6863498